BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gibbs SD, Sattianayagam PT, Hawkins PN, Gillmore JD. Cardiac transplantation should be considered in selected patients with either AL or hereditary forms of amyloidosis: the UK National Amyloidosis Centre experience. Intern Med J 2009;39:786-7; author reply 787-8. [PMID: 19912412 DOI: 10.1111/j.1445-5994.2009.02017.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sousa M, Monohan G, Rajagopalan N, Grigorian A, Guglin M. Heart transplantation in cardiac amyloidosis. Heart Fail Rev. 2017;22:317-327. [PMID: 28281017 DOI: 10.1007/s10741-017-9601-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
2 Perlini S, Mussinelli R, Salinaro F. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis. Curr Heart Fail Rep 2016;13:267-72. [PMID: 27900617 DOI: 10.1007/s11897-016-0311-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Schönland SO, Dreger P, de Witte T, Hegenbart U. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis. Bone Marrow Transplant 2012;47:895-905. [DOI: 10.1038/bmt.2011.152] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
4 Suhr OB, Larsson M, Ericzon BG, Wilczek HE. Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry. Transplantation. 2016;100:373-381. [PMID: 26656838 DOI: 10.1097/tp.0000000000001021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
5 Bradshaw SH, Veinot JP. Cardiac amyloidosis: what are the indications for transplant? Curr Opin Cardiol 2012;27:143-7. [PMID: 22314298 DOI: 10.1097/HCO.0b013e32834fdc7e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Macdonald P. Reply: Letters to the Editor. Internal Medicine Journal 2009;39:787-8. [DOI: 10.1111/j.1445-5994.2009.02057.x] [Reference Citation Analysis]
7 Patel KS, Hawkins PN. Cardiac amyloidosis: where are we today? J Intern Med 2015;278:126-44. [PMID: 26077367 DOI: 10.1111/joim.12383] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
8 Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation 2016;134:e579-646. [PMID: 27832612 DOI: 10.1161/CIR.0000000000000455] [Cited by in Crossref: 213] [Cited by in F6Publishing: 117] [Article Influence: 35.5] [Reference Citation Analysis]